Behçet’s disease. If you’ve never heard of it, it’s a disease that causes blood vessel inflammation.

If you have heard of it—or actually have Behçet’s—you’re probably well aware of the resulting skin rashes, eye inflammation, mouth sores, and genital sores.

Unfortunately, there’s no cure for Behçet’s, and the exact cause remains unknown, but folks are doing research to find ways to alleviate symptoms.

In fact, Celgene, a bio-pharmaceutical company, will be holding a clinical trial for RELIEF^TM (REsearching OraL ApremIlast Safety and EFficacy in Behçet’s Disease).  

The trial will study the effects of the drug Apremilast, in Behçet’s patients—particularly how it treats oral ulcers. The test should also help researchers learn more about how the body handles Apremilast in the system.

Interested? Here are the details:

• Celgene is looking for 204 male and female participants who are 18 and older and diagnosed with Behçet’s disease
• The study will require 15 clinical visits (one initial visit, 13 treatment visits, and one follow-up visit)
• Nine Study Center locations around the country will be participating in the trial
• Check out the website here

Have you participated in a clinical trial before? What should future participants know? Share your experience in a comment below!